↑ 疾患リストへ ← 戻る

 212. 三尖弁閉鎖症 [臨床試験数:4,薬物数:5(DrugBank:5),標的遺伝子数:6,標的パスウェイ数:5] 

Searched query = "Tricuspid atresia", "Single ventricular circulation syndrome"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollement
Last_Refreshed_
on
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00974025June 200916 December 2017Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated PatientsVitamin C May Improve Endothelial Function and Exercise Capacity in Functional Single Ventricle Patients After Fontan PalliationFontan Procedure;Hypoplastic Left Heart Syndrome;Tricuspid AtresiaDietary Supplement: Vitamin C;Dietary Supplement: PlaceboUniversity of MichiganGriese-Hutchinson Champions for Children's Hearts Investigator AwardNot recruiting8 Years25 YearsAll53N/AUnited States
2NCT00507819December 200719 October 2017Sildenafil After the Fontan OperationThe Sildenafil After Fontan Operation StudyHypoplastic Left Heart Syndrome;Tricuspid AtresiaDrug: Sildenafil;Drug: PlaceboChildren's Hospital of PhiladelphiaThe Mark H. and Blanche M. Harrington FoundationNot recruiting8 Years40 YearsAll28Phase 2United States
3NCT00573066May 200419 October 2017Understanding Dexmedetomidine In Infants Post-Operative From Cardiac SurgeryThe Pharmacokinetics, Pharmacogenetics, and Pharmacodynamics of Dexmedetomidine In Infants Post-Operative From Cardiac SurgeryHypoplastic Left Heart;Tetralogy of Fallot;Tricuspid AtresiaDrug: DexmedetomidineAthena ZuppaNot recruiting1 Month24 MonthsAll56Phase 1
4NCT00004828December 19947 April 2015Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan ProcedureTricuspid Atresia;Heart Defects, CongenitalDrug: liothyronine I 131FDA Office of Orphan Products DevelopmentChildren's Hospital and Health CenterNot recruitingN/A17 YearsBoth28Phase 1